Historical record - last NADAC effective date: 7/19/2023
Product Information
NORETHIN-ETH ESTRAD 1 MG-5 MCG is a generic product labeled by Nivagen Pharmaceuticals Inc., priced at $1.3970 per EA under NDC 75834013029. Its NADAC has been published 323 times since May 31, 2017.
FDA first approved this application on Jun 3, 2016. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
The High Outlier badge above means this manufacturer's average price in the Norethindrone Acetate and Ethinyl Estradiol market falls above Q3 + 1.5·IQR across all competing manufacturers. We only apply this flag in markets with four or more competitors. Full definition: glossary → outlier.
Strength
.005; 1 mg/1; mg/1
Manufacturer
Nivagen Pharmaceuticals Inc.NDC
75834013029
Classification
Generic
Dosage Form
TABLET
Route
ORAL
Effective Date
7/19/2023
Active Ingredients
ETHINYL ESTRADIOL; NORETHINDRONE ACETATEApproval Type
Generic (ANDA)
FDA Application
ANDA203435FDA Approved
6/3/2016
TE Code
AB
On Market Since
11/25/2016
Price Statistics
The NADAC for NORETHIN-ETH ESTRAD 1 MG-5 MCG has been published 323 times since May 31, 2017, and over the history we have for it it has declined 25.0%. The table below summarizes its recorded NADAC range and movement.
| Current price | $1.3970 per EA |
|---|---|
| All-time high | $2.0191 (Jan 10, 2018) |
| All-time low | $0.7471 (Dec 21, 2022) |
| Median price | $1.3307 |
| Average price | $1.3996 |
| Largest weekly change | +58.9% (Jan 18, 2023) |
| Weeks tracked | 323 |
| Tracking since | May 31, 2017 |
1W
N/A
1M
N/A
3M
N/A
6M
N/A
1Y
N/A
3Y
N/A
5Y
+8.1%
All
-25.0%
Last surveyed Aug 2, 2023 — this NDC no longer appears in the current weekly NADAC file.
Generic Alternatives
The matcher finds 1 manufacturer offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 60% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Frequently asked questions
What is the NADAC price of NORETHIN-ETH ESTRAD 1 MG-5 MCG?
The current National Average Drug Acquisition Cost (NADAC) for NORETHIN-ETH ESTRAD 1 MG-5 MCG, manufactured by Nivagen Pharmaceuticals Inc., is $1.3970 per EA (NDC 75834013029), effective Aug 2, 2023.
How has the price of NORETHIN-ETH ESTRAD 1 MG-5 MCG changed over time?
Over the history we have for it, the NADAC for NORETHIN-ETH ESTRAD 1 MG-5 MCG has declined 25.0%. It has been tracked across 323 weekly CMS publications since May 31, 2017.
What are the highest and lowest recorded NADAC prices for NORETHIN-ETH ESTRAD 1 MG-5 MCG?
Since May 31, 2017, the NADAC for NORETHIN-ETH ESTRAD 1 MG-5 MCG has ranged from a low of $0.7471 (Dec 21, 2022) to a high of $2.0191 (Jan 10, 2018), with a median of $1.3307 per EA.
Are there cheaper alternatives to NORETHIN-ETH ESTRAD 1 MG-5 MCG?
Yes. 1 manufacturer publishes a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, FYAVOLV 1 MG-5 MCG TABLET, is $0.5602 per EA — about 60% below NORETHIN-ETH ESTRAD 1 MG-5 MCG.
Who manufactures NORETHIN-ETH ESTRAD 1 MG-5 MCG?
NORETHIN-ETH ESTRAD 1 MG-5 MCG (NDC 75834013029) is labeled by Nivagen Pharmaceuticals Inc., and CMS classifies it as a generic product.